Cancer Research CTRC-AACR San Antonio Breast Cancer Symposium
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

Cancer Research 66, 10760-10769, November 15, 2006. doi: 10.1158/0008-5472.CAN-06-1111
© 2006 American Association for Cancer Research

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by van Gorp, A. G.M.
Right arrow Articles by Coffer, P. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by van Gorp, A. G.M.
Right arrow Articles by Coffer, P. J.

Molecular Biology, Pathobiology, and Genetics

Chronic Protein Kinase B (PKB/c-akt) Activation Leads to Apoptosis Induced by Oxidative Stress–Mediated Foxo3a Transcriptional Up-regulation

Ankie G.M. van Gorp1, Karen M. Pomeranz2, Kim U. Birkenkamp1, Rosaline C-Y. Hui2, Eric W-F. Lam2 and Paul J. Coffer1

1 Molecular Immunology Laboratory, Department of Immunology, University Medical Center Utrecht, Utrecht, the Netherlands and 2 Cancer Research-UK Laboratories and Section of Cancer Cell Biology, Department of Oncology, Imperial College School of Medicine, Hammersmith Hospital, London, United Kingdom

Requests for reprints: Paul J. Coffer, Molecular Immunology Laboratory, Department of Immunology, University Medical Center, KC.02.085.2, Lundlaan 6, 3584 CA Utrecht, the Netherlands. Phone: 31-30-250-7674; Fax: 31-30-250-4305; E-mail: P.J.Coffer{at}umcutrecht.nl.

Increased protein kinase B (PKB; c-Akt) activation is a hallmark of diverse neoplasias providing both proliferative and antiapoptotic survival signals. In this study, we investigated the effect of chronic PKB activation on cellular survival and proliferation using cytokine-dependent bone marrow–derived Ba/F3 cells, in which PKB{alpha} activation can be directly, and specifically, induced by addition of 4-hydroxytamoxifen (4-OHT). Direct activation of PKB rescued Ba/F3 cells from cytokine withdrawal–induced apoptosis; however, surprisingly, these antiapoptotic effects were short lived, cells only being protected for up to 48 hours. We observed that activation of PKB in survival factor–deprived cells led to a dramatic increase of Foxo3a on both the transcriptional and protein level leading to expression of its transcriptional targets Bim and p27kip1. High levels of PKB activity result in increased aerobic glycolysis and mitochondrial activity resulting in overproduction of reactive oxygen species. To determine whether oxidative stress might itself be responsible for Foxo3a up-regulation, we utilized hydrogen peroxide (H2O2) as an artificial inducer of oxidative stress and N-acetylcysteine (NAC), a thiol-containing radical oxygen scavenger. Addition of NAC to the culture medium prolonged the life span of cells treated with 4-OHT and prevented the up-regulation of Foxo3a protein levels caused by PKB activation. Conversely, treatment of Ba/F3 cells with H2O2 caused an increase of Foxo3a on both transcriptional and protein levels, suggesting that deregulated PKB activation leads to oxidative stress resulting in Foxo3a up-regulation and subsequently cell death. Taken together, our data provide novel insights into the molecular consequences of uncontrolled PKB activation. (Cancer Res 2006; 66(22): 10760-9)




This article has been cited by other articles:


Home page
Mol. Cell. Biol.Home page
R. C.-Y. Hui, A. R. Gomes, D. Constantinidou, J. R. Costa, C. T. Karadedou, S. Fernandez de Mattos, M. P. Wymann, J. J. Brosens, A. Schulze, and E. W.-F. Lam
The Forkhead Transcription Factor FOXO3a Increases Phosphoinositide-3 Kinase/Akt Activity in Drug-Resistant Leukemic Cells through Induction of PIK3CA Expression
Mol. Cell. Biol., October 1, 2008; 28(19): 5886 - 5898.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
L. Valenti, R. Rametta, P. Dongiovanni, M. Maggioni, A. Ludovica Fracanzani, M. Zappa, E. Lattuada, G. Roviaro, and S. Fargion
Increased Expression and Activity of the Transcription Factor FOXO1 in Nonalcoholic Steatohepatitis
Diabetes, May 1, 2008; 57(5): 1355 - 1362.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
S. Maddika, S. R. Ande, E. Wiechec, L. L. Hansen, S. Wesselborg, and M. Los
Akt-mediated phosphorylation of CDK2 regulates its dual role in cell cycle progression and apoptosis
J. Cell Sci., April 1, 2008; 121(7): 979 - 988.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
F. B. Berry, J. M. Skarie, F. Mirzayans, Y. Fortin, T. J. Hudson, V. Raymond, B. A. Link, and M. A. Walter
FOXC1 is required for cell viability and resistance to oxidative stress in the eye through the transcriptional regulation of FOXO1A
Hum. Mol. Genet., February 14, 2008; 17(4): 490 - 505.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2006 by the American Association for Cancer Research.